Back to results
US 2025/0367253 A1Published application
Gip/glp1 agonist compositions
AssigneeEli Lilly and Company
InventorsVincent John CORVARI, Christopher Sears MINIE, Dinesh Shyamdeo MISHRA, Ken Kangyi QIAN
Life of this patent
Estimating the term…
Abstract
A composition of tirzepatide, comprising an agent selected from NaCl and propylene glycol; and dibasic sodium phosphate is provided.
Claims9
1-43. (canceled)
A pharmaceutical composition comprising:
- (a) tirzepatide, or a pharmaceutically acceptable salt thereof;
- and
- (b) from about 6.2 mg/mL to about 9.5 mg/mL of NaCl, wherein the pharmaceutical composition has a pH of from about 6.5 to about 7.5 and the composition is free of preservative.
Dependencies are inferred from the claim text.